{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:12:19Z","timestamp":1759335139619,"version":"build-2065373602"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,19]],"date-time":"2025-08-19T00:00:00Z","timestamp":1755561600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.nbd.2025.107063","type":"journal-article","created":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T13:09:53Z","timestamp":1755695393000},"page":"107063","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["RGMA gene polymorphisms as predictive biomarkers for early relapse in neuromyelitis optica spectrum disorders"],"prefix":"10.1016","volume":"215","author":[{"given":"Xiaoyi","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Cui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinsong","family":"Jiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yeqiong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renbin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dantao","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weihe","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.nbd.2025.107063_bb0005","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1136\/jnnp-2014-308550","article-title":"Paediatric neuromyelitis optica: clinical, MRI of the brain and prognostic features","volume":"86","author":"Absoud","year":"2015","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"3","key":"10.1016\/j.nbd.2025.107063_bb0010","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/S1474-4422(22)00431-8","article-title":"Diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disease: international MOGAD panel proposed criteria","volume":"22","author":"Banwell","year":"2023","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.nbd.2025.107063_bb0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2024.105600","article-title":"FCGR3A-V158F gene polymorphism: a potential predictor for rituximab dosing optimization in Chinese patients with neuromyelitis optica spectrum disorder","volume":"86","author":"Cui","year":"2024","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"3","key":"10.1016\/j.nbd.2025.107063_bb0020","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1097\/WCO.0000000000000694","article-title":"Neuromyelitis optica spectrum disorders: still evolving and broadening","volume":"32","author":"Fujihara","year":"2019","journal-title":"Curr. Opin. Neurol."},{"issue":"5","key":"10.1016\/j.nbd.2025.107063_bb0025","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000841","article-title":"Interleukin-6 in neuromyelitis optica spectrum disorder pathophysiology","volume":"7","author":"Fujihara","year":"2020","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.nbd.2025.107063_bb0030","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s41232-017-0037-6","article-title":"The roles of RGMa-neogenin signaling in inflammation and angiogenesis","volume":"37","author":"Fujita","year":"2017","journal-title":"Inflamm. Regen."},{"issue":"1","key":"10.1016\/j.nbd.2025.107063_bb0035","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/s41598-017-18362-2","article-title":"Inhibition of RGMa alleviates symptoms in a rat model of neuromyelitis optica","volume":"8","author":"Harada","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.nbd.2025.107063_bb0040","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2021.743868","article-title":"Common polymorphisms in the RGMa promoter are associated with cerebrovascular atherosclerosis burden in Chinese Han patients with acute ischemic cerebrovascular accident","volume":"8","author":"Hu","year":"2021","journal-title":"Front. Cardiovasc. Med."},{"key":"10.1016\/j.nbd.2025.107063_bb0045","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1056944","article-title":"Age of onset correlates with clinical characteristics and prognostic outcomes in neuromyelitis optica spectrum disorder","volume":"13","author":"Hu","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.nbd.2025.107063_bb0050","doi-asserted-by":"crossref","DOI":"10.1177\/2633105520948481","article-title":"Repulsive guidance molecule a regulates adult neurogenesis via the Neogenin receptor","volume":"15","author":"Isaksen","year":"2020","journal-title":"Neurosci. Insights."},{"issue":"4","key":"10.1016\/j.nbd.2025.107063_bb0055","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.stemcr.2020.03.003","article-title":"Repulsive guidance molecule a suppresses adult neurogenesis","volume":"14","author":"Isaksen","year":"2020","journal-title":"Stem Cell Rep."},{"issue":"4","key":"10.1016\/j.nbd.2025.107063_bb0060","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1002\/ana.26327","article-title":"RGMa signal in macrophages induces neutrophil-related Astrocytopathy in NMO","volume":"91","author":"Iwamoto","year":"2022","journal-title":"Ann. Neurol."},{"issue":"1","key":"10.1016\/j.nbd.2025.107063_bb0065","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s12883-018-1056-x","article-title":"Dose effects of mycophenolate mofetil in Chinese patients with neuromyelitis optica spectrum disorders: a case series study","volume":"18","author":"Jiao","year":"2018","journal-title":"BMC Neurol."},{"key":"10.1016\/j.nbd.2025.107063_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2024.578297","article-title":"Inhibition of repulsive guidance molecule-a ameliorates compromised blood-spinal cord barrier integrity associated with neuromyelitis optica in rats","volume":"388","author":"Katsu","year":"2024","journal-title":"J. Neuroimmunol."},{"issue":"2","key":"10.1016\/j.nbd.2025.107063_bb0075","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1002\/ana.24554","article-title":"Neuromyelitis optica: evaluation of 871 attacks and 1,153 treatment courses","volume":"79","author":"Kleiter","year":"2016","journal-title":"Ann. Neurol."},{"issue":"3","key":"10.1016\/j.nbd.2025.107063_bb0080","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1007\/s11481-011-9334-z","article-title":"Repulsive guidance molecule-a and demyelination: implications for multiple sclerosis","volume":"7","author":"Kubo","year":"2012","journal-title":"J. NeuroImmune Pharmacol."},{"issue":"11","key":"10.1016\/j.nbd.2025.107063_bb0085","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1212\/WNL.33.11.1444","article-title":"Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS)","volume":"33","author":"Kurtzke","year":"1983","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2025.107063_bb0090","doi-asserted-by":"crossref","first-page":"62","DOI":"10.3389\/fneur.2017.00062","article-title":"Different phenotypes at onset in neuromyelitis Optica Spectrum disorder patients with Aquaporin-4 autoimmunity","volume":"8","author":"Long","year":"2017","journal-title":"Front. Neurol."},{"issue":"11","key":"10.1016\/j.nbd.2025.107063_bb0095","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1002\/acn3.51147","article-title":"Genetic factors for susceptibility to and manifestations of neuromyelitis optica","volume":"7","author":"Matsushita","year":"2020","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.nbd.2025.107063_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2022.105812","article-title":"Delayed administration of elezanumab, a human anti-RGMa neutralizing monoclonal antibody, promotes recovery following cervical spinal cord injury","volume":"172","author":"Mothe","year":"2022","journal-title":"Neurobiol. Dis."},{"issue":"4","key":"10.1016\/j.nbd.2025.107063_bb0105","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1038\/nm.2321","article-title":"RGMa modulates T cell responses and is involved in autoimmune encephalomyelitis","volume":"17","author":"Muramatsu","year":"2011","journal-title":"Nat. Med."},{"issue":"4","key":"10.1016\/j.nbd.2025.107063_bb0110","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/gene.2009.111","article-title":"RGMA and IL21R show association with experimental inflammation and multiple sclerosis","volume":"11","author":"Nohra","year":"2010","journal-title":"Genes Immun."},{"issue":"2","key":"10.1016\/j.nbd.2025.107063_bb0115","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/s41419-021-03469-2","article-title":"Inhibition of repulsive guidance molecule-a protects dopaminergic neurons in a mouse model of Parkinson\u2019s disease","volume":"12","author":"Oda","year":"2021","journal-title":"Cell Death Dis."},{"issue":"2","key":"10.1016\/j.nbd.2025.107063_bb0120","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1212\/WNL.0000000000011153","article-title":"Worldwide incidence and prevalence of neuromyelitis Optica: a systematic review","volume":"96","author":"Papp","year":"2021","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.nbd.2025.107063_bb0125","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000200124","article-title":"International delphi consensus on the management of AQP4-IgG+ NMOSD: recommendations for eculizumab, inebilizumab, and satralizumab","volume":"10","author":"Paul","year":"2023","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"issue":"12","key":"10.1016\/j.nbd.2025.107063_bb0130","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1038\/s41582-021-00568-8","article-title":"Hope for patients with neuromyelitis optica spectrum disorders - from mechanisms to trials","volume":"17","author":"Pittock","year":"2021","journal-title":"Nat. Rev. Neurol."},{"issue":"3","key":"10.1016\/j.nbd.2025.107063_bb0135","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1042\/BJ20090978","article-title":"Molecular biology, genetics and biochemistry of the repulsive guidance molecule family","volume":"422","author":"Severyn","year":"2009","journal-title":"Biochem. J."},{"issue":"17","key":"10.1016\/j.nbd.2025.107063_bb0140","doi-asserted-by":"crossref","first-page":"e1642","DOI":"10.1212\/WNL.0000000000006392","article-title":"Area postrema syndrome: frequency, criteria, and severity in AQP4-IgG-positive NMOSD","volume":"91","author":"Shosha","year":"2018","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.nbd.2025.107063_bb0145","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/0896-6273(90)90227-7","article-title":"Biochemical characterization of a putative axonal guidance molecule of the chick visual system","volume":"5","author":"Stahl","year":"1990","journal-title":"Neuron"},{"issue":"4","key":"10.1016\/j.nbd.2025.107063_bb0150","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1016\/j.celrep.2014.10.038","article-title":"Repulsive guidance molecule-a is involved in Th17-cell-induced neurodegeneration in autoimmune encephalomyelitis","volume":"9","author":"Tanabe","year":"2014","journal-title":"Cell Rep."},{"key":"10.1016\/j.nbd.2025.107063_bb0155","article-title":"Expression and clinical correlation analysis between repulsive guidance molecule a and neuromyelitis Optica Spectrum disorders","volume":"13","author":"Tang","year":"2022","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.nbd.2025.107063_bb0160","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3892\/mmr.2022.12601","article-title":"RGMa regulates CCL5 expression via the BMP receptor in experimental autoimmune encephalomyelitis mice and endothelial cells","volume":"25","author":"Tang","year":"2022","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.nbd.2025.107063_bb0165","article-title":"Incidence of neuromyelitis optica spectrum disorder (NMOSD) in China: a national population-based study","volume":"2","author":"Tian","year":"2020","journal-title":"Lancet Reg. Health West Pac."},{"issue":"3","key":"10.1016\/j.nbd.2025.107063_bb0170","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1002\/ana.20770","article-title":"Neuromyelitis optica IgG predicts relapse after longitudinally extensive transverse myelitis","volume":"59","author":"Weinshenker","year":"2006","journal-title":"Ann. Neurol."},{"issue":"5","key":"10.1016\/j.nbd.2025.107063_bb0175","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1212\/WNL.53.5.1107","article-title":"The clinical course of neuromyelitis optica (Devic\u2019s syndrome)","volume":"53","author":"Wingerchuk","year":"1999","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.nbd.2025.107063_bb0180","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","article-title":"International consensus diagnostic criteria for neuromyelitis optica spectrum disorders","volume":"85","author":"Wingerchuk","year":"2015","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.nbd.2025.107063_bb0185","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1002\/ana.26623","article-title":"Aquaporin-4 antibody dynamics and relapse risk in seropositive neuromyelitis Optica Spectrum disorder treated with immunosuppressants","volume":"93","author":"Yin","year":"2023","journal-title":"Ann. Neurol."},{"issue":"6","key":"10.1016\/j.nbd.2025.107063_bb0190","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1007\/s10753-022-01686-1","article-title":"Modulation of microglia M2 polarization and alleviation of hippocampal neuron injury by MiR-106b-5p\/RGMa in a mouse model of status epilepticus","volume":"45","author":"Yu","year":"2022","journal-title":"Inflammation"},{"key":"10.1016\/j.nbd.2025.107063_bb0195","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.jneuroim.2016.01.004","article-title":"Differentiation of neuromyelitis optica spectrum disorders from ultra-longitudinally extensive transverse myelitis in a cohort of Chinese patients","volume":"291","author":"Zhang","year":"2016","journal-title":"J. Neuroimmunol."},{"issue":"4","key":"10.1016\/j.nbd.2025.107063_bb0200","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1007\/s00415-019-09685-3","article-title":"Questioning the existence of monophasic neuromyelitis optica spectrum disorder by defining a novel long-term relapse-free form from a large Chinese population","volume":"267","author":"Zhang","year":"2020","journal-title":"J. Neurol."},{"issue":"7","key":"10.1016\/j.nbd.2025.107063_bb0205","doi-asserted-by":"crossref","first-page":"9151","DOI":"10.1007\/s12035-025-04840-6","article-title":"Pilot exploration of RGMa-BMP4 Signaling in neutrophil activation in NMOSD: integrating clinical and molecular insights","volume":"62","author":"Zhang","year":"2025","journal-title":"Mol. Neurobiol."}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996125002797?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996125002797?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T06:21:39Z","timestamp":1759299699000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996125002797"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":41,"alternative-id":["S0969996125002797"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2025.107063","relation":{},"ISSN":["0969-9961"],"issn-type":[{"type":"print","value":"0969-9961"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"RGMA gene polymorphisms as predictive biomarkers for early relapse in neuromyelitis optica spectrum disorders","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbd.2025.107063","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"107063"}}